George Matcham
Direttore/Membro del Consiglio presso INSTIL BIO, INC.
Patrimonio netto: 419 269 $ in data 31/05/2024
Profilo
George Matcham is an Independent Director at Instil Bio, Inc. He previously served as a Non-Executive Director at Chimeric Therapeutics Ltd.
(Australia) from 2021 to 2023.
Prior to that, he held the position of SVP-CAR T CMC & Technology Development at Celgene Corp.
from 2017 to 2018.
He also worked as the Chief Operating Officer at Celgene Cellular Therapeutics.
Dr. Matcham completed his graduate degree at the University of Cambridge and holds undergraduate and doctorate degrees from the University of Cardiff.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
INSTIL BIO, INC.
0.59% | 13/06/2024 | 38 100 ( 0.59% ) | 407 289 $ | 31/05/2024 |
| 21/09/2023 | 1 000 800 ( 0.12% ) | 11 980 $ | 31/05/2024 |
Posizioni attive di George Matcham
| Società | Posizione | Inizio |
|---|---|---|
| INSTIL BIO, INC. | Direttore/Membro del Consiglio | 01/09/2018 |
Precedenti posizioni note di George Matcham
| Società | Posizione | Fine |
|---|---|---|
| CHIMERIC THERAPEUTICS LIMITED | Direttore/Membro del Consiglio | 03/08/2023 |
| CELGENE | Corporate Officer/Principal | 01/06/2018 |
Celgene Cellular Therapeutics
 Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Direttore operativo | - |
Formazione di George Matcham
| University of Cambridge | Graduate Degree |
| University of Cardiff | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| INSTIL BIO, INC. | Health Technology |
| CHIMERIC THERAPEUTICS LIMITED | Health Technology |
| Aziende private | 2 |
|---|---|
Celgene Corp.
 Celgene Corp. BiotechnologyHealth Technology Celgene Corp. is an integrated global biopharmaceutical company, which engages in the discovery, development and commercialization of therapies for the treatment of cancer and inflammatory diseases. Its primary commercial stage products include Revlimid, Pomalyst, Imnovid, Otezla, Abraxane, and Vidaza. The company was founded by David Stirling and Sol Barer in 1986 and is headquartered in Summit, NJ. | Health Technology |
Celgene Cellular Therapeutics
Celgene Cellular Therapeutics Pharmaceuticals: MajorHealth Technology Part of Bristol Myers Squibb Co., Celgene Cellular Therapeutics develops human pharmaceuticals. The company is based in Warren, NJ. The company was founded by Robert Joseph Hariri Gordon. | Health Technology |
- Borsa valori
- Insiders
- George Matcham
